These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25190114)

  • 1. Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up.
    Henry LR; Hostetter RB; Ressler B; Bowser I; Yan M; Vaghefi H; Abad J; Gulec S; Schwarz RE
    Ann Surg Oncol; 2015 Feb; 22(2):467-74. PubMed ID: 25190114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis.
    Maker AV; August C; Maker VK; Weisenberg E
    J Gastrointest Surg; 2016 Apr; 20(4):869-70. PubMed ID: 26847353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after repeat hepatic resection for recurrent colorectal metastases.
    Chiappa A; Zbar AP; Biella F; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (90) Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes.
    Lewandowski RJ; Donahue L; Chokechanachaisakul A; Kulik L; Mouli S; Caicedo J; Abecassis M; Fryer J; Salem R; Baker T
    J Surg Oncol; 2016 Jul; 114(1):99-105. PubMed ID: 27103352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Y-90 Radioembolization After Prior Major Hepatic Resection.
    Zimmermann M; Schulze-Hagen M; Liebl M; Pedersoli F; Goerg F; Ulmer TF; Heinzel A; Isfort P; Kuhl C; Bruners P
    Cardiovasc Intervent Radiol; 2017 Aug; 40(8):1206-1212. PubMed ID: 28357572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
    Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
    J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
    J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors.
    Bester L; Feitelson S; Milner B; Chua TC; Morris DL
    Am J Clin Oncol; 2014 Oct; 37(5):454-60. PubMed ID: 23388564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
    J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
    Cardona K; Donataccio D; Kingham TP; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Cercek A; Kemeny NE; D'Angelica MI
    Ann Surg Oncol; 2014 Mar; 21(3):815-21. PubMed ID: 24242675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of resection influences outcome following hepatectomy for colorectal liver metastases.
    Stewart GD; O'Súilleabháin CB; Madhavan KK; Wigmore SJ; Parks RW; Garden OJ
    Eur J Surg Oncol; 2004 May; 30(4):370-6. PubMed ID: 15063889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors.
    Michl M; Haug AR; Jakobs TF; Paprottka P; Hoffmann RT; Bartenstein P; Boeck S; Haas M; Laubender RP; Heinemann V
    Oncology; 2014; 86(1):24-32. PubMed ID: 24401529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
    Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
    J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.
    Saxena A; Kapoor J; Meteling B; Morris DL; Bester L
    Ann Surg Oncol; 2014 Apr; 21(4):1296-303. PubMed ID: 24337647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key.
    Tsim N; Healey AJ; Frampton AE; Habib NA; Bansi DS; Wasan H; Cleator SJ; Stebbing J; Lowdell CP; Jackson JE; Tait P; Jiao LR
    Ann Surg Oncol; 2011 Jul; 18(7):1939-46. PubMed ID: 21298352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience.
    Melstrom LG; Eng OS; Raoof M; Singh G; Fong Y; Latorre K; Choi GH; Salem R; Bentrem DJ; Lewandowski R; Makris E; Poultsides G; Dhar VK; Chadalavada S; Shah SA; Johnson AC; Sekhar A; Kies D; Maithel SK; Rocha F; Alseidi A; Hagendoorn J; Borel Rinkes IHM; Fisher AV; Ronnekleiv-Kelly S; Weber SM; Winslow ER; Abbott DE
    HPB (Oxford); 2019 Nov; 21(11):1520-1526. PubMed ID: 31005493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.
    Kuo JC; Tazbirkova A; Allen R; Kosmider S; Gibbs P; Yip D
    Asia Pac J Clin Oncol; 2014 Sep; 10(3):266-72. PubMed ID: 25135200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.
    Iñarrairaegui M; Pardo F; Bilbao JI; Rotellar F; Benito A; D'Avola D; Herrero JI; Rodriguez M; Martí P; Zozaya G; Dominguez I; Quiroga J; Sangro B
    Eur J Surg Oncol; 2012 Jul; 38(7):594-601. PubMed ID: 22440743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.